A crystallographic and molecular modeling study of butyrophenones

Journal of Pharmaceutical Sciences

Volumn 87, Issue 12, 1998, Pages 1496-1500

  Liang, Li ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLSPIPERONE; BUTYROPHENONE DERIVATIVE; FLUSPIRILENE; PIMOZIDE; SPIPERONE;

ARTICLE; CRYSTAL STRUCTURE; MOLECULAR MODEL; X RAY CRYSTALLOGRAPHY;

EID: 0031742175     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980253e     Document Type: Article

References (18)

1. Klein, C. L.; Lear, J.; O'Rourke, S.; Williams, S.; Liang, L. Crystal and Molecular Structure of Tricyclic Neuroleptics. J. Pharm. Sei. 1994, 83(9), 1253-1256.
2. Klein, C. L.; Welch, J.; Southall, L. C. Structure of DroperidolEthanol(l/l). Acta Crystallogr. 1989, C45, 650-653.
3. Quick, M.; Iverson, L. Regional Study of 3H-spiperone binding and the dopamine-Sensitive Adenylate Cyclase in Rat Brain. EUT. J. Pharmacol. 1979, 56, 323-330.
4. Bacopoulos, N. G.; Ware, P. L. Dopamine Receptors in Rat Frontal Cortex: Pharmacological Properties in vivi and in vitro. Life Sei. 1980, 27, 2489-2494.
5. Burns, H. D.; Dannais, R. F.; Langstrom, B.; Ravert, H. T.; Zemyan, S. E.; Duelfer, T.; Wong, D. F.; Frost, J. J.; Kuhar, M. J.; Wagner, H. N. (3-N[nC]Methyl)spiperone, a Ligand Binding to Dopamine Receptors: Radiochemical Synthesis and Biodistrihution Studies in Mice. J. Nucl. Med. 1984, 25(11), 1222-1227.
6. Physicians Desk Reference, 46 ed.; Medical Economics Company, Litton division: Oradell, NJ, 1992.
7. Galizzi, J.-P.; Fosset, M.; Romey, G.; Laduron, P.; Lazdunski, M. Neuroleptics of the Diphenylbutylpiperidine series are potent calcium channel inhibitors. Proc. Nat. Acad. Sei. U.S.A. 1986, 83(19), 7513-7517.
8. Janssen, P. A. J.; Niemegeers, C. J. E.; Schellekens, K. H. L.; Lenaerts, F. M.; Verbruggen, F. J.; VanNueten, J. M.; Marsboom, R. H. M.; Herin, V. V.; Schaper, W. K. A. Pharmacology of Fluspirilene (R6218) [8-[4,4-bis(p-Fluorophenyl)butyl]-l-phenyl-l,3,8-triazino[4,4]decan-4-one] a Potent, Long-acting and Injectable Neuroleptic Drug. Arzneimittel-Forsch. 1970,20(11), 1689-1698.
9. Main, P.; Fiske, S. J.; Hüll, S. E.; Lessinger, L.; Germain, G.; Declercq, J.-P.; Woolfson, M. M. MULTAN11/82. A System of Computer Programs for the Automatic Solution of Crystal Structures from X-ray Diffraction Data; Univs. of York, England and Louvain, Belgium.
10. MolEN, Structure Determination System of programs used for the processing, solving, and interpretation of the data was written by C. K. Fair, 1990.
11. International Tables for X-ray Crystallography; Kynoch Press: Birmingham, England, 1974; Vol. IV, pp 71-151.
12. Conventional reliability indices: R = X∥F∥ - ∥FC∥/I∥F0∥, and A = (I(∥F0∥ - lFc∥)2/lwjF0∥2)1/2, where F0 and Fc are observed and calculated structure factors, w = 1/oiF)2, and where a(F) is the estimated standard deviation in F0.
13. Gajewski, J. J.; Gilbert, K. E.; McKelvey, J. MMX, An Enhanced Version of MM2. Adv. Mol. Model. 1990, 2, 6592.
14. Koch, M. H. J. The Crystal and Molecular Structure of 8-[3(p-fluorobenzoyl)propyl]-l-phenyl-l,3,8-triazaspiro[4,5]decan4-one, C23H26N3O2F. Acta Crystallogr. 1973, B29, 379-382.
15. Azibi, M.; Draguet-Brughmans, M.; Bouche, R.; Tinant, B.; Germain, G.; Declercq, J. P.; van Meerssche, M. Conformational Study of Two Polymorphs of Spiperone: Possible Consequences on the Interpretation of Pharmacological Activity. J. Pharm. Sei. 1983, 72(3), 232-235.
16. Blaton, N. M.; Peeters, O. M.; DeRanter, C. J. l-{l-[4-(4-Fluorophenyl)-4-oxobutyl]-l,2,3,6-tetrahydro-4-pyridyl}-l,3-dihydro- 2£f-benzimidazol-2-one Dihydrate (Dehydrobenzperidol). Acta Crystallogr. 1980, B36, 2828-2830.
17. Reed, L. L.; Schaefer, J. P. The Crystal and Molecular Structure of Haloperidol, a Potent Psychotropic Drug. Acta Crystallogr. 1973, 529, 1886-1890.
18. Datta, N.; Mondai, P.; Pauling, P. The Structure of Haloperidol Hydrobromide {4-[4-(4-chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone HBr}. Acta Crystallogr. 1979, 535, 1486-1488.